Scientists test new arthritis drug on healthy volunteers
NCT ID NCT07182656
Summary
This is the first study in humans for a potential new rheumatoid arthritis drug called CIGB-814. Researchers are testing it on 70 healthy volunteers to check if it's safe, see how the body processes it, and observe its early effects on the immune system. The goal is to gather basic safety information before testing it in people who actually have rheumatoid arthritis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 101149, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.